Icotrokinra vs Semax
Overview
Icotrokinra is primarily a immune support peptide, while Semax is used for cognitive enhancement.
This page compares Icotrokinra and Semax across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Icotrokinra | Semax | |
|---|---|---|
| Category | Immune Support | Cognitive Enhancement |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | — | 300-600 mcg |
| Frequency | — | daily |
| Reported benefits | — | Enhanced focus and memory, neuroprotection, improved learning, mood enhancement, stress resilience |
| Reported side effects | — | Generally safe. Possible: overstimulation, sleep disturbances if taken late |
Key differences
Primary use. Icotrokinra is categorised under Immune Support, while Semax falls under Cognitive Enhancement. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Icotrokinra: FDA-approved. Semax: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Typical dosing for Icotrokinra is not catalogued. Semax is typically dosed at 300-600 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Icotrokinra and Semax has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Icotrokinra and Semax?
- Icotrokinra is primarily a immune support peptide, while Semax is used for cognitive enhancement. Icotrokinra is FDA-approved for one or more indications, whereas Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- What is Semax used for?
- Cognitive enhancement, focus, memory.
- Can you take Icotrokinra and Semax together?
- Some users combine peptides within a single protocol, but stacking Icotrokinra and Semax has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Icotrokinra or Semax FDA-approved?
- Icotrokinra is FDA-approved for one or more indications. Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Icotrokinra — full monograph: mechanism, research, dosing & references
- Semax — full monograph: mechanism, research, dosing & references